JENNIFER BRADLEY: Open Payments
NPI 1013978089 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,202 in 70 payments from 13 companies in 2025. Trend: 2023 $20,904 · 2024 $3,755 · 2025 $16,202
Speaker / faculty: $15,000Food & beverage: $840Travel & lodging: $261Education: $101
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $15,632 |
| Teva Pharmaceuticals USA, Inc. | 1 | $101 |
| E.R. Squibb & Sons, L.L.C. | 5 | $98 |
| Janssen Pharmaceuticals, Inc | 4 | $80 |
| Alkermes, Inc. | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
| Almatica Pharma LLC | 3 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| HARMONY BIOSCIENCES LLC | 1 | $21 |
Products named: VRAYLAR, COBENFY, INVEGA SUSTENNA, CAPLYTA, LOREEV XR, REXULTI, ARISTADA, TRINTELLIX.
Industry payments across IA — which companies pay providers there.
